Apomorphine and propranolol in the treatment of alcoholism
Carlsson, C.; Fasth, B.G.
Lakartidningen 71(34): 3074-3076
1974
ISSN/ISBN: 0023-7205 PMID: 4408586 Document Number: 75525
Document emailed within 1 workday
Related Documents
Jaillon, P.; Hecklé, J.; Weissenburger, J.; Cheymol, G. 1980: Cardiac electrophysiologic properties of dl-propranolol, d-propranolol, l-propranolol and dl-pindolol in anesthetized dogs Journal of Pharmacology and Experimental Therapeutics 212(2): 347-353Ziegler, B.; Schneider, E. 1974: Treatment of withdrawal syndrome with apomorphine Arzneimittel-Forschung 24(8): 1117-1119
Albani, C.; Zangger, I.; Fischer, G. 1992: Subcutaneous apomorphine infusion in the treatment of Parkinson disease Schweizerische Rundschau für Medizin Praxis 81(35): 1011-1015
Grandas, F.J.; Sesar-Ignacio, Án. 2012: Subcutaneous continuous apomorphine infusion: treatment initiation and follow up Revista de Neurologia 55(Suppl 1): S21-S24
Merello, M.; Leiguarda, R. 1995: Treatment of motor fluctuations in Parkinson's disease with subcutaneous injections of apomorphine Medicina 55(1): 5-10
Giménez de Béjar, V.ón.; Carballo-Cordero, M. 2012: Treatment of apomorphine infusion adverse effects: subcutaneous nodules and neuropsychiatric complications Revista de Neurologia 55(Suppl 1): S25-S29
Roffman, M.; Cordasco, F.; Kling, A. 1980: Apomorphine-induced stereotypy in mature and senescent rats following cessation of chronic haloperidol treatment Communications in Psychopharmacology 4(4): 283-286
Martin, J.R.; Quock, R.M. 1979: Stabilization of apomorphine induced hypothermia in the Okamoto-Aoki spontaneously hypertensive rat by chronic lithium treatment Proceedings of the Western Pharmacology Society 22: 143-144
Murakami, E.; Shiosaka, S.; Tohyama, M. 1981: Does fluorescent analogue of propranolol, 9-amino-acridine-propranolol, binding sites really show the beta-adrenoreceptors? Cellular and Molecular Biology Including Cyto-Enzymology 27(2-3): 133-137
Leysen, J.E. 1980: 3H-Apomorphine receptors in various rat brain regions: a study of specific and nonspecific binding and the influence of chronic neuroleptic treatment Advances in Biochemical Psychopharmacology 24: 123-132
Albani, F.; Riva, R.; Baldrati, A.; Cortelli, P.; Perucca, E.; Procaccianti, G.; Baruzzi, A. 1984: Plasma concentrations of propranolol and 4-hydroxy-propranolol at steady-state in neurological patients: intersubject and intrasubject correlations with dose International Journal of Clinical Pharmacology Research 4(1): 19-23
Ongcharit, C.; Tungsanga, K. 1977: Propranolol and propranolol with thiazide in hypertensive Thai patients Journal of the Medical Association of Thailand 60(10): 465-469
Grosz, H.J. 1972: Successful treatment of a heroin addict with propranolol: implications for opiate addiction, treatment and research Journal of the Indiana State Medical Association 65(6): 505-509
Hesselbrock, V.; Bauer, L.; O'Connor, S.; Gillen, R. 1993: Reduced P300 amplitude in relation to family history of alcoholism and antisocial personality disorder among young men at risk for alcoholism Alcohol and Alcoholism . Suppl 2: 95-100
Vaniukov, M.M.; Moskalenko, V.D.; Kogan, B.M. 1987: Alcoholism and heredity: biological basis of the predisposition to alcoholism Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 4: 3-8
Feuerlein, W.; Ringer, C.; Küfner, H.; Antons, K. 1977: Diagnosis of alcoholism. the Munich Alcoholism test (MALT) Münchener Medizinische Wochenschrift 119(40): 1275-1282
Karlberg, B. 1970: Propranolol treatment of thyrotoxicosis Lakartidningen 67(50): 5917-5922
1973: Treatment of alcoholism. 3 Maryland State Medical Journal 22(5): 67-75
Vachonfrance, G. 1973: Treatment of alcoholism Revue de l'Infirmiere 23(3): 231-234
Kryspin-Exner, K. 1979: Treatment of alcoholism Der Nervenarzt 50(5): 277-285